Jolyon Jesty

3.8k total citations
83 papers, 3.2k citations indexed

About

Jolyon Jesty is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Jolyon Jesty has authored 83 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Hematology, 26 papers in Cardiology and Cardiovascular Medicine and 17 papers in Genetics. Recurrent topics in Jolyon Jesty's work include Blood Coagulation and Thrombosis Mechanisms (36 papers), Hemophilia Treatment and Research (19 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (16 papers). Jolyon Jesty is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (36 papers), Hemophilia Treatment and Research (19 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (16 papers). Jolyon Jesty collaborates with scholars based in United States, United Kingdom and Netherlands. Jolyon Jesty's co-authors include Danny Bluestein, Yale Nemerson, Edward Beltrami, Gaurav Girdhar, Wei Yin, Jawaad Sheriff, Wadie F. Bahou, M. P. Esnouf, Humayun Mirza and Michalis Xenos and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Jolyon Jesty

82 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jolyon Jesty United States 34 1.5k 799 612 599 517 83 3.2k
James C. Fredenburgh Canada 34 1.4k 1.0× 757 0.9× 654 1.1× 461 0.8× 565 1.1× 79 3.4k
Theo Lindhout Netherlands 29 1.7k 1.1× 540 0.7× 518 0.8× 418 0.7× 471 0.9× 68 2.8k
Armin J. Reininger Germany 27 1.6k 1.1× 887 1.1× 689 1.1× 612 1.0× 330 0.6× 64 2.8k
LV McIntire United States 19 1.2k 0.8× 452 0.6× 639 1.0× 427 0.7× 296 0.6× 28 2.4k
Pierre Mangin France 38 2.1k 1.4× 942 1.2× 665 1.1× 517 0.9× 740 1.4× 104 3.9k
Timothy M. Wick United States 27 859 0.6× 340 0.4× 424 0.7× 596 1.0× 1.1k 2.1× 50 4.0k
J J Sixma Netherlands 39 3.3k 2.2× 957 1.2× 1.3k 2.1× 959 1.6× 704 1.4× 103 5.7k
Vincent T. Turitto United States 36 2.3k 1.5× 1.2k 1.6× 1.7k 2.8× 973 1.6× 280 0.5× 69 4.6k
Erik Westein Australia 22 1.4k 0.9× 642 0.8× 813 1.3× 452 0.8× 339 0.7× 32 2.7k
Kjell S. Sakaríassen Norway 38 2.6k 1.7× 1.8k 2.2× 1.2k 1.9× 1.3k 2.1× 646 1.2× 112 5.0k

Countries citing papers authored by Jolyon Jesty

Since Specialization
Citations

This map shows the geographic impact of Jolyon Jesty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jolyon Jesty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jolyon Jesty more than expected).

Fields of papers citing papers by Jolyon Jesty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jolyon Jesty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jolyon Jesty. The network helps show where Jolyon Jesty may publish in the future.

Co-authorship network of co-authors of Jolyon Jesty

This figure shows the co-authorship network connecting the top 25 collaborators of Jolyon Jesty. A scholar is included among the top collaborators of Jolyon Jesty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jolyon Jesty. Jolyon Jesty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ghebrehiwet, Berhane, Jolyon Jesty, Yan Ji, et al.. (2011). Structure?Function Studies Using Deletion Mutants Identify Domains of gC1qR/p33 as Potential Therapeutic Targets for Vascular Permeability and Inflammation. SHILAP Revista de lepidopterología. 2. 19 indexed citations
2.
Sheriff, Jawaad, Danny Bluestein, Gaurav Girdhar, & Jolyon Jesty. (2010). High-Shear Stress Sensitizes Platelets to Subsequent Low-Shear Conditions. Annals of Biomedical Engineering. 38(4). 1442–1450. 132 indexed citations
3.
Xenos, Michalis, Gaurav Girdhar, Yared Alemu, et al.. (2010). Device Thrombogenicity Emulator (DTE) − Design optimization methodology for cardiovascular devices: A study in two bileaflet MHV designs. Journal of Biomechanics. 43(12). 2400–2409. 94 indexed citations
4.
Girdhar, Gaurav, Jawaad Sheriff, Yasushi Kato, et al.. (2010). Thrombogenic Potential of Innovia Polymer Valves versus Carpentier-Edwards Perimount Magna Aortic Bioprosthetic Valves. ASAIO Journal. 57(1). 26–31. 32 indexed citations
5.
Peerschke, Ellinor I.B., et al.. (2009). Structure-function analysis of gC1qR/p33 using deletion mutants show additional binding sites for C1q. (134.69). The Journal of Immunology. 182(Supplement_1). 134.69–134.69. 1 indexed citations
6.
Scudder, L E, et al.. (2008). Altered bioavailability of platelet-derived factor VIII during thrombocytosis reverses phenotypic efficacy in haemophilic mice. Thrombosis and Haemostasis. 100(12). 1111–1122. 12 indexed citations
7.
Girdhar, Gaurav, Suheng Xu, Danny Bluestein, & Jolyon Jesty. (2008). Reduced-nicotine cigarettes increase platelet activation in smokers in vivo: A dilemma in harm reduction. Nicotine & Tobacco Research. 10(12). 1737–1744. 18 indexed citations
8.
Girdhar, Gaurav, et al.. (2008). In Vitro Model of Platelet-Endothelial Activation Due to Cigarette Smoke Under Cardiovascular Circulation Conditions. Annals of Biomedical Engineering. 36(7). 1142–1151. 11 indexed citations
9.
Ghebrehiwet, Berhane, et al.. (2007). gC1qR/p33 Serves as a Molecular Bridge between the Complement and Contact Activation Systems and Is an Important Catalyst in Inflammation. Advances in experimental medicine and biology. 586. 95–105. 38 indexed citations
10.
Rubenstein, David A., et al.. (2006). Platelet factor V supports hemostasis in a patient with an acquired factor V inhibitor, as shown by prothrombinase and tenase assays. Blood Coagulation & Fibrinolysis. 17(7). 593–597. 19 indexed citations
11.
12.
Jesty, Jolyon, et al.. (2005). Demonstration of a Threshold Response in a Proteolytic Feedback System: Control of the Autoactivation of Factor XII. Pathophysiology of Haemostasis and Thrombosis. 34(2-3). 71–79. 15 indexed citations
13.
Bahou, Wadie F., L E Scudder, David A. Rubenstein, & Jolyon Jesty. (2004). A Shear-restricted Pathway of Platelet Procoagulant Activity Is Regulated by IQGAP1. Journal of Biological Chemistry. 279(21). 22571–22577. 25 indexed citations
14.
Yin, Wei, Yared Alemu, K. Affeld, Jolyon Jesty, & Danny Bluestein. (2004). Flow-Induced Platelet Activation in Bileaflet and Monoleaflet Mechanical Heart Valves. Annals of Biomedical Engineering. 32(8). 1058–1066. 87 indexed citations
15.
Yin, Wei, Yared Alemu, Jolyon Jesty, & Danny Bluestein. (2004). Effects of Valve Design and Orientation on Flow Induced Platelet Activation in Mechanical Heart Valves. Advances in Bioengineering. 37–38. 2 indexed citations
16.
Beltrami, Edward & Jolyon Jesty. (2001). The role of membrane patch size and flow in regulating a proteolytic feedback threshold on a membrane: possible application in blood coagulation. Mathematical Biosciences. 172(1). 1–13. 33 indexed citations
17.
18.
Kurtz, Richard M. & Jolyon Jesty. (1994). The Mechanisms of Coagulation.. The Science Teacher. 61(9). 30–33. 6 indexed citations
19.
Hultin, MB & Jolyon Jesty. (1992). Factor VIIA levels in patients with hemophilia [letter; comment]. Blood. 80(12). 3255–3256. 2 indexed citations
20.
Neuenschwander, Pierre F. & Jolyon Jesty. (1990). The use of acetylated factor X to prevent feedback activation of factor VIII during factor X activation: A tool for kinetic studies. Analytical Biochemistry. 184(2). 347–352. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James C. Fredenburgh Breakdown of academic impact, for papers by Theo Lindhout Breakdown of academic impact, for papers by Armin J. Reininger Breakdown of academic impact, for papers by LV McIntire Breakdown of academic impact, for papers by Pierre Mangin Breakdown of academic impact, for papers by Timothy M. Wick Breakdown of academic impact, for papers by J J Sixma Breakdown of academic impact, for papers by Vincent T. Turitto Breakdown of academic impact, for papers by Erik Westein Breakdown of academic impact, for papers by Kjell S. Sakaríassen
Rankless by CCL
2026